Stem Cell Banking Market Size and Forecast Research Report 2024

1. Biotechnology Stem Cell Banking Market Size, Share, Development, Growth and Demand Forecast to 2024 © P&S Intelligence. All rights reserved 1

2. Stem cells are the cells that have the potential to differentiate into various types of cells in the body. Embryonic stem cells and adult stem cells are the two main types of stem cells. Stem cells could possibly be used to generate cells and tissues for therapy of a variety of diseases including Alzheimer's disease, Parkinson's disease, heart disease, spinal cord injury, diabetes, and arthritis. The global stem cell banking market size is expected to grow due to the increasing prevalence of such diseases and increasing awareness among people about the need to preserve stem cells. The umbilical cord blood of the newborn is an abundant source of stem cells. However, some tissues and organs within body, skin, blood, and the lining of intestine are also key source of tissue- specific stem cells. The stem cells are separated from the blood or tissue, processed, tested and preserved in a stem cell bank. These stored stem cells have application in treating various types of blood disease as well as genetic disorders such as sickle cell anemia, thalassemia, leukemia, and immune disorders. According to the National Cancer Institute, the incidence of leukemia was 13.7 per 100,000 men and women per year between 2010 to 2014 in the U.S. Therefore, the overall demand for stem cell based therapies and stem cell banking is increasing, which is expected to drive the growth of the global stem cell banking market. National Cancer Institute a part of the National Institutes of Health (NIH), is the principal agency for cancer training and research of the U.S. Federal Government. Request for sample copy of this report at: https://www.psmarketresearch.com/market- analysis/stem-cell-banking-market/report-sample Growth Drivers The stem cell market is expected to grow during the forecast period mainly due to the easy extraction methods used and increasing awareness about stem cell therapeutics and their potential in treating various diseases. According to World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012 and the number of new cases are expected to rise by about 70% over the next two decades. With promising results with stem cell therapies in treating such disorders, the increased incidence of these disease is expected to act as a driving factor for the growth of the global stem cell banking market. Restraints The stem cell banking involves high operating cost for the umbilical cord processing and storage. Many people do not opt for stem cell banking due to lack of awareness and high cost of stem cell therapy. Also, frequent changes in legal regulations related to stem cell banking hinder the growth of the global stem cell banking market. Insights by Geography North America holds the largest share in the global stem cell banking market since the majority of stem cell banking players are based in the region. The growth in the North American stem cell © P&S Intelligence. All rights reserved 2

3. banking industry is mainly due to the increase in awareness among people regarding stem cell banks. The Asia-Pacific stem cell banking market is expected to grow at the fastest rate during the forecast period due to the increasing investment by government and development of new technologies, which leads to the growth in the emerging countries such as China, Japan and India. Browse full report at: https://www.psmarketresearch.com/market-analysis/stem-cell-banking- market Competitive Landscape Many players in the global stem cell banking market are collaborating to expand their presence in new geographies and also to get access to the proprietary technologies of other companies. In June 2017, LifeCodexx AG, a provider of non-invasive prenatal DNA testing in the Europe, announced its partnership with LifeCell International Pvt. Ltd., an Indian mother & baby preventive health care provider, to bring PrenaTesT, qNIPT testing for the first time to India. The qNIPT technology that detects the presence of foetal trisomy 21 (Down Syndrome) from maternal blood, received CE marking (European Conformity) in December 2016. Some of the major players operating in the stem cell banking market include Cordlife Group Ltd, Cryocell International, Inc., Lifecell International Pvt. Ltd., PerkinElmer, Inc. (Viacord), StemCyte Inc., CryoSave AG, China Cord Blood Corporation, Cord Blood America, Inc., Caladrius Biosciences Inc., CBR Systems, Inc., Cordvida, Cordviva India. MARKET SEGMENTATION By Bank Type  Cord Blood  Cord Tissue By Service  Collection and Transportation  Processing  Analysis  Storage By Application  Cerebral Palsy  Thalassemia  Cancer Diseases  Diabetes  Autism  Others By Region © P&S Intelligence. All rights reserved 3

4.  oU.S. oCanada  Europe oU.K. oGermany oFrance oItaly oSpain oRest of Europe  Asia-Pacific oJapan oChina oIndia oAustralia oRest of Asia-Pacific  Latin America oBrazil oMexico oRest of Latin America  Middle East & Africa (MEA) oSouth Africa oRest of MEA North America © P&S Intelligence. All rights reserved 4

5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved 5